Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights
07 août 2018 16h07 HE
|
Voyager Therapeutics, Inc.
Clinical data updates and regulatory feedback for VY-AADC during the quarter support planned pivotal program for Parkinson’s disease Pipeline programs progressing with updated preclinical data from...